Skip to main content
. 2019 Jun 13;11(1):142–150. doi: 10.1111/jdi.13075

Figure 6.

Figure 6

Seven‐point self‐monitored blood glucose (SMBG) profiles by time of assessment at baseline and week 26 in Chinese patients with type 2 diabetes who were treated with dulaglutide 1.5 mg, dulaglutide 0.75 mg or glimepiride. *P < 0.05 versus glimepiride; **P < 0.001 versus glimepiride; ***P < 0.001 versus glimepiride.